Your browser doesn't support javascript.
loading
Urinary B-cell-activating factor of the tumour necrosis factor family (BAFF) in systemic lupus erythematosus.
Vincent, F B; Kandane-Rathnayake, R; Hoi, A Y; Slavin, L; Godsell, J D; Kitching, A R; Harris, J; Nelson, C L; Jenkins, A J; Chrysostomou, A; Hibbs, M L; Kerr, P G; Rischmueller, M; Mackay, F; Morand, E F.
Afiliação
  • Vincent FB; 1 Centre for Inflammatory Diseases, Monash University School of Clinical Sciences at Monash Health, Melbourne, Victoria, Australia.
  • Kandane-Rathnayake R; 1 Centre for Inflammatory Diseases, Monash University School of Clinical Sciences at Monash Health, Melbourne, Victoria, Australia.
  • Hoi AY; 1 Centre for Inflammatory Diseases, Monash University School of Clinical Sciences at Monash Health, Melbourne, Victoria, Australia.
  • Slavin L; 1 Centre for Inflammatory Diseases, Monash University School of Clinical Sciences at Monash Health, Melbourne, Victoria, Australia.
  • Godsell JD; 1 Centre for Inflammatory Diseases, Monash University School of Clinical Sciences at Monash Health, Melbourne, Victoria, Australia.
  • Kitching AR; 1 Centre for Inflammatory Diseases, Monash University School of Clinical Sciences at Monash Health, Melbourne, Victoria, Australia.
  • Harris J; 2 Department of Nephrology, Monash Health, and Monash University, Clayton, Victoria, Australia.
  • Nelson CL; 1 Centre for Inflammatory Diseases, Monash University School of Clinical Sciences at Monash Health, Melbourne, Victoria, Australia.
  • Jenkins AJ; 3 Western Health, Department of Nephrology, St Albans, Victoria, Australia.
  • Chrysostomou A; 4 The Department of Medicine, Western Health, The University of Melbourne, St Albans, Victoria, Australia.
  • Hibbs ML; 5 National Health and Medical Research Council (NHMRC) Clinical Trials Centre, University of Sydney, Camperdown, New South Wales, Australia.
  • Kerr PG; 6 The Renal Unit, The Alfred Hospital, Prahran, Victoria, Australia.
  • Rischmueller M; 7 Department of Immunology and Pathology, Monash University, Central Clinical School, Melbourne, Victoria, Australia.
  • Mackay F; 2 Department of Nephrology, Monash Health, and Monash University, Clayton, Victoria, Australia.
  • Morand EF; 8 Rheumatology Department, The Queen Elizabeth Hospital, and Discipline of Medicine, University of Adelaide, Adelaide, South Australia, Australia.
Lupus ; 27(13): 2029-2040, 2018 Nov.
Article em En | MEDLINE | ID: mdl-30301439

Texto completo: 1 Coleções: 01-internacional Temas: Cuidados_paliativos / Geral Base de dados: MEDLINE Assunto principal: Nefrite Lúpica / Fator Ativador de Células B / Lúpus Eritematoso Sistêmico Tipo de estudo: Observational_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Oceania Idioma: En Revista: Lupus Assunto da revista: REUMATOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Temas: Cuidados_paliativos / Geral Base de dados: MEDLINE Assunto principal: Nefrite Lúpica / Fator Ativador de Células B / Lúpus Eritematoso Sistêmico Tipo de estudo: Observational_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Oceania Idioma: En Revista: Lupus Assunto da revista: REUMATOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Austrália